A promising new stroke drug that temporarily inhibits a key protein in the brain without causing lasting harm may significantly change the future treatment of cerebral and global ischemia, according to a new study by scientists at the University of Colorado Anschutz Medical Campus.
CU Anschutz
Fitzsimons Building
13001 East 17th Place
Aurora, CO 80045